Psychemedics EPS - Earnings per Share 2010-2024 | PMD

Psychemedics eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Psychemedics Annual EPS
2023 $-0.72
2022 $-0.19
2021 $-0.12
2020 $-0.70
2019 $0.28
2018 $0.83
2017 $1.10
2016 $1.22
2015 $0.28
2014 $0.60
2013 $0.72
2012 $0.57
2011 $0.67
2010 $0.50
2009 $0.29
Psychemedics Quarterly EPS
2024-09-30 $-0.09
2024-06-30 $-0.14
2024-03-31 $-0.12
2023-12-31 $-0.16
2023-09-30 $-0.36
2023-06-30 $-0.13
2023-03-31 $-0.07
2022-12-31 $-0.12
2022-09-30 $-0.02
2022-06-30 $-0.06
2022-03-31 $0.01
2021-12-31 $-0.28
2021-09-30 $0.13
2021-06-30 $0.02
2021-03-31 $0.01
2020-12-31 $-0.10
2020-09-30 $-0.20
2020-06-30 $-0.37
2020-03-31 $-0.03
2019-12-31 $-0.09
2019-09-30 $0.12
2019-06-30 $0.14
2019-03-31 $0.11
2018-12-31 $0.16
2018-09-30 $0.23
2018-06-30 $0.21
2018-03-31 $0.23
2017-12-31 $0.42
2017-09-30 $0.25
2017-06-30 $0.16
2017-03-31 $0.27
2016-12-31 $0.43
2016-09-30 $0.49
2016-06-30 $0.30
2016-03-31 $0.00
2015-12-31 $0.03
2015-09-30 $0.15
2015-06-30 $0.05
2015-03-31 $0.05
2014-12-31 $0.13
2014-09-30 $0.17
2014-06-30 $0.16
2014-03-31 $0.14
2013-12-31 $0.16
2013-09-30 $0.20
2013-06-30 $0.20
2013-03-31 $0.16
2012-12-31 $0.05
2012-09-30 $0.17
2012-06-30 $0.19
2012-03-31 $0.16
2011-12-31 $0.09
2011-09-30 $0.21
2011-06-30 $0.21
2011-03-31 $0.16
2010-12-31 $0.07
2010-09-30 $0.16
2010-06-30 $0.17
2010-03-31 $0.10
2009-12-31 $0.10
2009-09-30 $0.15
2009-06-30 $0.03
2009-03-31 $0.01
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00